Acute ST-segment Elevation Myocardial Infarction
7
0
0
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention
Prognostic Implication of Angiography-Derived IMR in STEMI Patients
DCB Under the Guidance of OCT in STEMI
Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients
EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction
The RESTORE-SIRIO Randomized Controlled Trial
Effects of Glucagon Like Peptide-1 on No-reflow